BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25380164)

  • 1. Costs of cardiovascular disease prevention care and scenarios for cost saving: a micro-costing study from rural Nigeria.
    Hendriks ME; Bolarinwa OA; Nelissen HE; Boers AC; Gomez GB; Tan SS; Redekop W; Adenusi P; Lange JM; Agbede K; Akande TM; Schultsz C
    J Hypertens; 2015 Feb; 33(2):376-684. PubMed ID: 25380164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and quality of cardiovascular disease prevention within a community-based health insurance program in rural Nigeria: an operational cohort study.
    Hendriks ME; Bolarinwa OA; Wit FW; Brewster LM; Odusola AO; Rosendaal NT; Bindraban NR; Adenusi P; Agbede K; Lange JM; Akande TM; Schultsz C
    J Hypertens; 2015 Feb; 33(2):366-75. PubMed ID: 25380163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease prevention in rural Nigeria in the context of a community based health insurance scheme: QUality Improvement Cardiovascular care Kwara-I (QUICK-I).
    Hendriks M; Brewster L; Wit F; Bolarinwa OA; Odusola AO; Redekop W; Bindraban N; Vollaard A; Alli S; Adenusi P; Agbede K; Akande T; Lange J; Schultsz C
    BMC Public Health; 2011 Mar; 11():186. PubMed ID: 21439057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and Cost-Effectiveness of Hypertension Screening and Treatment in Adults with Hypertension in Rural Nigeria in the Context of a Health Insurance Program.
    Rosendaal NT; Hendriks ME; Verhagen MD; Bolarinwa OA; Sanya EO; Kolo PM; Adenusi P; Agbede K; van Eck D; Tan SS; Akande TM; Redekop W; Schultsz C; Gomez GB
    PLoS One; 2016; 11(6):e0157925. PubMed ID: 27348310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving Maternal Care through a State-Wide Health Insurance Program: A Cost and Cost-Effectiveness Study in Rural Nigeria.
    Gomez GB; Foster N; Brals D; Nelissen HE; Bolarinwa OA; Hendriks ME; Boers AC; van Eck D; Rosendaal N; Adenusi P; Agbede K; Akande TM; Boele van Hensbroek M; Wit FW; Hankins CA; Schultsz C
    PLoS One; 2015; 10(9):e0139048. PubMed ID: 26413788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health system costs of rheumatic heart disease care in South Africa.
    Hellebo AG; Zuhlke LJ; Watkins DA; Alaba O
    BMC Public Health; 2021 Jul; 21(1):1303. PubMed ID: 34217236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of the treatment of uncomplicated severe acute malnutrition by community health workers compared to treatment provided at an outpatient facility in rural Mali.
    Rogers E; Martínez K; Morán JLA; Alé FGB; Charle P; Guerrero S; Puett C
    Hum Resour Health; 2018 Feb; 16(1):12. PubMed ID: 29458382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic cost of primary prevention of cardiovascular diseases in Tanzania.
    Ngalesoni F; Ruhago G; Norheim OF; Robberstad B
    Health Policy Plan; 2015 Sep; 30(7):875-84. PubMed ID: 25113027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enablers and barriers for implementing high-quality hypertension care in a rural primary care setting in Nigeria: perspectives of primary care staff and health insurance managers.
    Odusola AO; Stronks K; Hendriks ME; Schultsz C; Akande T; Osibogun A; van Weert H; Haafkens JA
    Glob Health Action; 2016; 9():29041. PubMed ID: 26880152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of a cardiovascular disease primary prevention programme in a primary health care setting. Results of the Polish part of the EUROACTION project.
    Sović N; Pająk A; Jankowski P; Duenas A; Kawecka-Jaszcz K; Wolfshaut-Wolak R; Stepaniak U; Kawalec P
    Kardiol Pol; 2013; 71(7):702-11. PubMed ID: 23907903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of primary care approaches for hypertension management and risk-based cardiovascular disease prevention in Bangladesh: a HEARTS costing tool application.
    Husain MJ; Haider MS; Tarannum R; Jubayer S; Bhuiyan MR; Kostova D; Moran AE; Choudhury SR
    BMJ Open; 2022 Jun; 12(6):e061467. PubMed ID: 35760540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Step-by-step guideline for disease-specific costing studies in low- and middle-income countries: a mixed methodology.
    Hendriks ME; Kundu P; Boers AC; Bolarinwa OA; Te Pas MJ; Akande TM; Agbede K; Gomez GB; Redekop WK; Schultsz C; Swan Tan S
    Glob Health Action; 2014; 7():23573. PubMed ID: 24685170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic appraisal of a community-wide cardiovascular health awareness program.
    Goeree R; von Keyserlingk C; Burke N; He J; Kaczorowski J; Chambers L; Dolovich L; Michael Paterson J; Zagorski B
    Value Health; 2013; 16(1):39-45. PubMed ID: 23337214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease.
    Lamotte M; Annemans L; Evers T; Kubin M
    Pharmacoeconomics; 2006; 24(2):155-69. PubMed ID: 16460136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF Study.
    Pastori D; Farcomeni A; Pignatelli P; Violi F; Lip GY
    Am J Med; 2019 Jul; 132(7):856-861. PubMed ID: 30659810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of a statewide public health intervention to reduce cardiovascular disease risk.
    Smith L; Atherly A; Campbell J; Flattery N; Coronel S; Krantz M
    BMC Public Health; 2019 Sep; 19(1):1234. PubMed ID: 31492118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of a fixed dose combination (polypill) in secondary prevention of cardiovascular diseases in India: Within-trial cost-effectiveness analysis of the UMPIRE trial.
    Singh K; Crossan C; Laba TL; Roy A; Hayes A; Salam A; Jan S; Lord J; Tandon N; Rodgers A; Patel A; Thom S; Prabhakaran D
    Int J Cardiol; 2018 Jul; 262():71-78. PubMed ID: 29622506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost analysis of the WHO-HEARTS program for hypertension control and CVD prevention in primary health facilities in Ethiopia.
    Beshah SA; Husain MJ; Dessie GA; Worku A; Negeri MG; Banigbe B; Moran AE; Basu S; Kostova D
    Public Health Pract (Oxf); 2023 Dec; 6():100423. PubMed ID: 37727705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of a community health worker strategy for providing near and appropriate treatment of malaria in southeast Nigeria: an analysis of activities, costs and outcomes.
    Onwujekwe O; Uzochukwu B; Ojukwu J; Dike N; Shu E
    Acta Trop; 2007 Feb; 101(2):95-105. PubMed ID: 17270139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation and Prediction of Avoidable Health Care Costs of Cardiovascular Diseases and Type 2 Diabetes Through Adequate Dairy Food Consumption: A Systematic Review and Micro Simulation Modeling Study.
    Javanbakht M; Jamshidi AR; Baradaran HR; Mohammadi Z; Mashayekhi A; Shokraneh F; Rezai Hamami M; Yazdani Bakhsh R; Shabaninejad H; Delavari S; Tehrani A
    Arch Iran Med; 2018 May; 21(5):213-222. PubMed ID: 29738265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.